December 17, 2021
Advance Online
Advance Online
FDA Approves YUSIMRY
A biosimilar to Humira is approved for the treatment of PsA and plaque psoriasis.
A biosimilar to Humira is approved for the treatment of PsA and plaque psoriasis.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.